Astringent rule
This article was originally published in The Rose Sheet
Executive Summary
Effective date for direct final rule for astringents marketed under the OTC Skin Protectant Monograph is June 13, 2004, FDA says in a Jan. 22 Federal Register notice correcting an earlier published effective date of Oct. 27, 2003. FDA published an amended final rule for skin protectant astringent drug products in June and included small packaging exemptions and minor labeling changes along with the incorrect effective date (1"The Rose Sheet" June 16, 2003, p. 10)...
You may also be interested in...
Astringent Final Rule Contains Revised Labeling, Small Package Exemptions
The Skin Protectant Astringent direct final rule includes minor labeling changes and small packaging exemptions to bring the astringent portion of the Skin Protectant Monograph in line with the rest of the rule, FDA says. The agency published the direct final rule in the Federal Register June 13
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.